Skip to content
Bored Studies
RecruitingAccepts healthy volunteersMentions an overnight / inpatient stay

Sickle Cell Disease and the Genomic and Gene Therapy Needs of Stakeholders

St. Jude Children's Research Hospital · with National Heart, Lung, and Blood Institute (NHLBI) · NCT04416178

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 13+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
352
US sites recruiting
1
Study start
December 17, 2020
Record last updated
May 1, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The primary objectives of this prospective mixed-method interview study are to use semi-structured interviews in parents of sickle cell disease (SCD) patients to describe parental attitudes of research involving genomic sequencing, including concerns about participation and expectations from researchers and second, to use surveys to quantitatively measure genetic/genomic knowledge, trust in health care provider, and literacy/numeracy ability in parents of children with SCD and adolescents with SCD. Secondary objectives are development of a web-based tool about treatment options for SCD that fosters patient-clinician communication and promotes shared decision-making. The web-based tool will undergo usability and pilot testing to ensure it is accessible to families and provide data about strategies for integrating into clinical conversations about treatment options.

Investigators will use the data generated to reduce the risk of misunderstanding about DNA and genetic research and build strong relationships between SCD families and researchers in the future. The project will design educational information and study materials to help parents of children with SCD understand important details about genomic medicine in SCD care.

Conditions: Sickle Cell Disease

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

Group 1 (Survey and Interview) Participants only:

  • Parent of child with HbSS, HbS/ β0thalassemia, or HbSC aged 12 months to 18 years at study initiation, irrespective of clinical severity or patient aged 13-18 with aforementioned SCD genotype.
  • Informed consent from parent or legal guardian and assent of adolescent participant.
  • Has been previously approached for SCRIPP.

Group 2 (Focus Group) Participants only:

  • Adult Patient with or Parent of child with HbSS, HbS/ β0thalassemia, β+ thalassemia or HbSC aged 12 months to 18 years at study initiation, irrespective of clinical severity or patient aged 16-18 with aforementioned SCD genotype.
  • Informed consent from parent or legal guardian and assent of adolescent participant.

Group 3 (Usability and Pilot Testing) Participants only:

  • Parent of child with HbSS, HbS/ β0thalassemia, β+ thalassemia or HbSC aged 12 months to 18 years at study initiation, irrespective of clinical severity or patient aged 13 and up with aforementioned SCD genotype.
  • Informed consent from parent or legal guardian and assent of adolescent participant.

Exclusion Criteria (All groups):

  • Participants who are unable to converse fluently in English will be excluded. (Permanent)
  • Condition or chronic illness, which in the opinion of the PI/Co-I, makes participation unsafe or untenable (i.e. cognitive impairment, concurrent acute morbidity). Participant may be re-evaluated.
  • Inability or unwillingness of research participant or legal guardian/representative to give written informed consent.

Recruiting US locations

  • St. Jude Children's Research Hospital

    Memphis, TN 38105

    Site contact: Liza M. Johnson, MD, MPH, MSB · 888-226-4343 · referralinfo@stjude.org

Study contacts (from the official record)

  • Liza M. Johnson, MD, MPH, MSB · 888-226-4343 · referralinfo@stjude.org
All healthy volunteers studies in Tennessee →
Sickle Cell Disease and the Genomic and Gene Therapy Needs of… (NCT04416178) | Bored Studies